Article

Redox modulation of cell surface protein thiols in U937 lymphoma cells: the role of gamma-glutamyl transpeptidase-dependent H2O2 production and S-thiolation.

Institute of General Pathology, University of Siena, Italy.
Free Radical Biology and Medicine (Impact Factor: 5.71). 10/1999; 27(5-6):623-35. DOI: 10.1016/S0891-5849(99)00111-2
Source: PubMed

ABSTRACT The expression of gamma-glutamyl transpeptidase (GGT), a plasma membrane ectoenzyme involved in the metabolism of extracellular reduced glutathione (GSH), is a marker of neoplastic progression in several experimental models, and occurs in a number of human malignant neoplasms and their metastases. Because it favors the supply of precursors for the synthesis of GSH, GGT expression has been interpreted as a member in cellular antioxidant defense systems. However, thiol metabolites generated at the cell surface during GGT activity can induce prooxidant reactions, leading to production of free radical oxidant species. The present study was designed to characterize the prooxidant reactions occurring during GGT ectoactivity, and their possible effects on the thiol redox status of proteins of the cell surface. Results indicate that: (i) in U937 cells, expressing significant amounts of membrane-bound GGT, GGT-mediated metabolism of GSH is coupled with the extracellular production of hydrogen peroxide; (ii) GGT activity also results in decreased levels of protein thiols at the cell surface; (iii) GGT-dependent decrease in protein thiols is due to sulfhydryl oxidation and protein S-thiolation reactions; and (iv) GGT irreversible inhibition by acivicin is sufficient to produce an increase of protein thiols at the cell surface. Membrane receptors and transcription factors have been shown to possess critical thiols involved in the transduction of proliferative signals. Furthermore, it was suggested that S-thiolation of cellular proteins may represent a mechanism for protection of vulnerable thiols against irreversible damage by prooxidant agents. Thus, the findings reported here provide additional explanations for the envisaged role played by membrane-bound GGT activity in the proliferative attitude of malignant cells and their resistance to prooxidant drugs and radiation therapy.

2 Followers
 · 
87 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: zet Gama glutamil transferaz birbirine benzemeyen iki alt üniteden oluşmuş bir hücre yüzey glikoproteinidir. Serumdaki gama glutamil transferaz'ın en önemli kaynağı karaciğerdir ve böbrek tubülleri, safra epiteli ve beyin kapillerinde yüksek miktarda sentez edilir. Gama glutamil transferaz safra yoluyla ilişkili hastalıkların teşhisinde kullanılan çok önemli bir tanısal testtir. Hücrede gama glutamil transferaz'ın asıl görevi hücre dışında bulunan indirgenmiş glutatyonu yıkmak ve hücre içi glutatyon sentezi için öncül aminoasitleri temin etmektir. Bununla birlikte, gama glutamil transferaz antioksidan/anti-toksik savunma ve hücresel proliferasyon/apopitozis dengesi gibi önemli indirgeyici olayların düzenlenmesine aracılık eden önemli bir enzimdir. Son deneysel çalışmalarda hücresel gama glutamil transferaz'ın demir ve diğer geçiş metallerinin varlığında reaktif oksijen türlerinin oluşumunu artırabileceği bildirilmiştir. Serum gama glutamil transferaz aktivitesindeki artış ve günümüzde önemli ölüm ve sakatlıklara yol açan koroner kalp hastalığı, kanser, diabetes mellitus ve inme gibi hastalıklar arasındaki ilişkiyi araştıran çok sayıda çalışma vardır. Kanser hücrelerinin kemoterapötik ilaçlara direnciyle GGT aktivitesinin artışı arasında bir ilişki olduğu da bildirilmektedir. Bu derlemede gama glutamil transferaz'ın klinik kullanım alanları, fizyolojik rolü ve epidemiyolojik çalışma sonuçlarıyla ilgili bilgilerin özetlenmesi amaçlanmıştır. Anahtar kelimeler: Gama glutamil transferaz, kanser, kardiyovasküler hastalıklar diabetes mellitus Gama glutamil transferaz (GGT) (EC 2.3.2.2) veya diğer bilinen ismiyle gama glutamil transpeptidaz (gluta-mine:D-glutamyl-peptide 5-glutamyltransferase) serumda ve birçok hücrenin dış yüzeyinde bulunan ve aminoasit veya küçük peptidlerin gama glutamil artıklarının transferini kataliz eden bir enzimdir (1). Dokulardan elde edilen GGT moleküler ağırlık ve yüküne bağlı olarak önemli farklılıklar göstermektedir. Dolayısıyla GGT izoenzimleri de serum ve dokuya bağlı olarak birbirinden farklılık göstermektedir. Moleküler ağırlığı 68000 Dalton olan bir glikoprotein yapısındadır ve birbirine benzemeyen iki alt üniteden oluşmuştur. GGT esas olarak yüksek miktarda salgılama ve emilim kapasitesine sahip (safra kanalı, karaciğer kanalikülleri, proksimal böbrek tubülleri, pankreas asiner hücreleri, pankreas duktulleri ve ince barsak fırça kenar hücreleri) hücre
  • [Show abstract] [Hide abstract]
    ABSTRACT: The expression of gamma-glutamyl transpeptidase (GGT) is essential to maintaining cysteine levels in the body. GGT is a cell surface enzyme that hydrolyzes the gamma-glutamyl bond of extracellular reduced and oxidized glutathione, initiating their cleavage into glutamate, cysteine (cystine), and glycine. GGT is normally expressed on the apical surface of ducts and glands, salvaging the amino acids from glutathione in the ductal fluids. GGT in tumors is expressed over the entire cell membrane and provides tumors with access to additional cysteine and cystine from reduced and oxidized glutathione in the blood and interstitial fluid. Cysteine is rate-limiting for glutathione synthesis in cells under oxidative stress. The induction of GGT is observed in tumors with elevated levels of intracellular glutathione. Studies in models of hepatocarcinogenesis show that GGT expression in foci of preneoplastic hepatocytes provides a selective advantage to the cells during tumor promotion with agents that deplete intracellular glutathione. Similarly, expression of GGT in tumors enables cells to maintain elevated levels of intracellular glutathione and to rapidly replenish glutathione during treatment with prooxidant anticancer therapy. In the clinic, the expression of GGT in tumors is correlated with drug resistance. The inhibitors of GGT block GGT-positive tumors from accessing the cysteine in extracellular glutathione. They also inhibit GGT activity in the kidney, which results in the excretion of GSH in the urine and a rapid decrease in blood cysteine levels, leading to depletion of intracellular GSH in both GGT-positive and GGT-negative tumors. GGT inhibitors are being developed for clinical use to sensitize tumors to chemotherapy.
    Advances in Cancer Research 01/2014; 122C:103-141. DOI:10.1016/B978-0-12-420117-0.00003-7 · 4.26 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a key redox-sensitive protein, the activity of which is largely affected by oxidative modifications at its highly reactive cysteine residue in the active site of the enzyme (Cys-152). These modifications occur as a result of S-thiolation, S-nitrosylation or disulfide bonds that lead to aggregate formation. The oxidative changes not only affect the glycolytic function but also stimulate the participation of GAPDH in numerous cellular processes. In this review we describe how thiol modification of Cys-152 in GAPDH re-routes metabolic pathways in the cell and converts a metabolic enzyme into a pro-apoptotic factor. Especially interesting issue is the participation of GAPDH in the regulation of expression of endothelin 1 and nitrosylation of nuclear proteins. In the last section we describe involvement of GAPDH in the processes associated with neurodegenerative diseases.
    Postępy Higieny i Medycyny Doświadczalnej (Advances in Hygiene and Experimental Medicine) 01/2014; 68:280-90. DOI:10.5604/17322693.1093929

Full-text (3 Sources)

Download
101 Downloads
Available from
Nov 14, 2014

View other sources